Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Iliac Stent Market, by Artery Lesions
1.4.2 North America Iliac Stent Market, by End-use
1.4.3 North America Iliac Stent Market, by Type
1.4.4 North America Iliac Stent Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Iliac Stent Market by Artery Lesions
4.1 North America Common Iliac Artery Lesions Market by Country
4.2 North America Severe Calcified Lesions Market by Country
4.3 North America Complete Obstructive Lesions Market by Country
Chapter 5. North America Iliac Stent Market by End-use
5.1 North America Hospitals Market by Country
5.2 North America Outpatient Facilities Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Iliac Stent Market by Type
6.1 North America Self-expandable Stents Market by Country
6.2 North America Balloon-expandable Stents Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Iliac Stent Market by Country
7.1 US Iliac Stent Market
7.1.1 US Iliac Stent Market by Artery Lesions
7.1.2 US Iliac Stent Market by End-use
7.1.3 US Iliac Stent Market by Type
7.2 Canada Iliac Stent Market
7.2.1 Canada Iliac Stent Market by Artery Lesions
7.2.2 Canada Iliac Stent Market by End-use
7.2.3 Canada Iliac Stent Market by Type
7.3 Mexico Iliac Stent Market
7.3.1 Mexico Iliac Stent Market by Artery Lesions
7.3.2 Mexico Iliac Stent Market by End-use
7.3.3 Mexico Iliac Stent Market by Type
7.4 Rest of North America Iliac Stent Market
7.4.1 Rest of North America Iliac Stent Market by Artery Lesions
7.4.2 Rest of North America Iliac Stent Market by End-use
7.4.3 Rest of North America Iliac Stent Market by Type
Chapter 8. Company Profiles
8.1 Becton, Dickinson, and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Trials and Approvals:
8.1.6 SWOT Analysis
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Trials and Approvals:
8.3.6 SWOT Analysis
8.4 W. L. Gore & Associates, Inc.
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 Medtronic PLC
8.5.1 Company overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Trials and Approvals:
8.5.6 SWOT Analysis
8.6 Cook Medical, Inc. (Cook Group)
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Terumo Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Trials and Approvals:
8.7.5.2 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 iVascular S.L.U.
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Getinge AB
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Trials and Approvals:
8.9.6 SWOT Analysis
8.10. Biotronik SE & Co. KG
8.10.1 Company Overview
8.10.2 SWOT Analysis
Unique Offerings 